PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
3.635
+0.045 (1.25%)
Nov 17, 2025, 4:00 PM EST - Market closed
PolyPid Market Cap
PolyPid has a market cap or net worth of $60.47 million as of November 18, 2025. Its market cap has increased by 177.74% in one year.
Market Cap
60.47M
Enterprise Value
46.02M
1-Year Change
177.74%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $60.47M, a decrease of -26.65%. That is a compound annual growth rate of -5.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 60.47M | 192.36% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | 183.09M | 122.11% |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |